Untitled Deck Flashcards
(405 cards)
BLOOD COMPATIBILITY
WHOLE BLOODABO/Rh IdenticalRBC/Products containing RBCs: must be compatible with recipient’s plasma
O: O
A: A, O
B: B, O
AB: A, B, AB, O
Plasma/product containing plasma including cryoprecipitate and platelet: must be compatible with recipient’s RBC
O: O, A, B, AB
AB: AB
A: A, AB
B: B, AB
AB-type donor: universal plasma donor
O-type donor: universal RBC donor
BLOOD RECIPIENT TESTING
ABO and RH
Forward and reverse (A1 and B) typing and D-test
Discrepancies: give O until resolved
Common cause of discrepancies: extreme age (elderly and neonate), inability to produce antibody (hematology malignancy, immunocompromised, immunosuppressive drugs)
ANTIBODY SCREEN
To detect unexpected alloantibodies
Using 2-4 phenotyped O type RBCs, that covers all 18 clinically significant antibodies
O type RBC reagent is reacted with recipient’s plasma/serum
IS, 37 degree and AHG
IS/room temp incubation is often skipped because it’s only detecting clinically significant antibodies (M, Lewis, I, P, N)
If negative, proceed to XM
If positive, full ABID using 14 O-type cell panels
CROSSMATCH
EXM, IS at room temperature, pre-warmed
Infant less than 4 months: XM is not needed
ABO/Rh type is tested like adult, but only need to be tested once (unless the patient 1) discharged and readmitted, 2) stays beyond 4 months of age)– infant or mother’s serum can be used for ABID
BLOOD DONOR TESTING
ABO TESTINGABO forward and ABO reverse with A1 and B cellsRH TESTING
Anti-D test,
If D test is negative, perform weak D test including extended incubation and AHG step
If any D test is positive, label it as Rh+
ANTIBODY SCREENFor donor who was transfused or pregnant beforeINFECTIOUS DISEASE TESTING
All must be negative
Only one test is needed during each 30 days period
Must proof negative antibody and NAAT
HBV, HCV, HIV, Babesia, HTLV, WNV, Zika, T. cruzii
ANTIBACTERIAL FOR PLATELET
Prepared platelet culture is done after 24 hrs incubation and perform follow up culture after 3 days or negative bacterial antigen testing prior to transfusion
Large volume delayed sample (LVDS): culture after 36 hours after 12 hrs incubation
EXCEPTIONS
Infectious disease testing can be bypassed during emergency shortage with medical directors at both donor and transfusion centers release signature.
Must be done as soon as able
Omission is included on the label
False negative syphilis
BLOOD DONOR ADVERSE REACTION
Hypotension (increased HR, syncope)– IV fluid
Vasovagal (dizziness, low BP, low HR, syncope)– elevated feet, cold compress
Hyperventilation– breath to paper bag
Hematoma/bleeding– compression
Citrate toxicity (hypocalcemia symptom)– calcium gluconate, slow infusion CG
BLOOD COLLECTION SYSTEM
Correct labeling
If platelet is going to be harvested, diversion pouch must be attached: remove the first 30-45 mL blood consist of skin plug
Spiking: reduce the shelf life
Volume: 10.5 mL/Kg body weight, equal to ~15% total body weight
If plasma and platelet will be collected: the entire volume must be collected within 15 minutes
Typical bag: has anticoagulant appropriate for 450 +/- 45 mL blood
If only 350-404 mL collected in 450 mL bag or 333-449 mL in 500 mL bag: must be labeled with RBC low volume and cannot be used for preparation of other components.
Unit must be processed within 8 hour if plasma and platelet will be harvested
Transport: 1-10 degC
If platelet will be harvested: room temperature or 20-24 degC
AUTOMATED APHERESIS DONATION
Platelet
Regular: <= 2x/week with minimum interval of 2 days
Non regular: 4 weeks apart
CBC: minimum of 150K plt count is required
RBCs
Single pheresis donation with platelet and/or plasma: defer 8 weeks
Double RBC donation: defer for 16 weeks
The volume of RBCs removed must not causing the donor H/H to be <= 10/30
AUTOLOGUS DONOR REQUIREMENT
Physician’s order
Hgb >=11 g/dL, Ht >=33%
At least 72 hours prior to scheduled surgery
The unit is only for autologus donation
No potential of having bacteremia
Dutasteride blood donation deferral
Dutasteride: 6 months from last dose
BLOOD DONATION 3 MONTHS DEFERRAL
Receiving oral HIV PREP
CSW or having sexual relationship with CSW
New sex partner/multiple sex partner/anal sex
Positive screen/positive/treated for GO and syphilis
Tattoo or piercing
Sexual contact with HIV+ or HIV HR
Received blood product, human tissue or human derived clotting factor
Needle prick or mucous membrane exposure to blood
Use non-prescription injection drugs
Travel to malaria endemic area
Live in malaria pandemic area for > 5 years blood donation deferral
3 Years:
BLOOD DONATION INDEFINITE DEFERRAL
Family history of CJD
Clinical and laboratory proof of current or past T. cruzii and HTLV
Allogenic duramater transplant recipient and human pituitary growth hormone recipient
HIV+ (abs repeat or NAAT)
HBsAg+ or repeat HBcAg
Receiving HIV HAART
Recipient of live cells, tissue or non-human organ from animal source
Blood pressure and HR DONOR REQS
Pulse between 50-100. Less than 50 is OK for healthy athlete
BP
Lewis Blood Group
FUT3/Le encoded enzyme for fucosyl transferase, which adds fucose to Type 1 H antigen and make Le-a and Le-b
Le-a can be made if Le is present
Le-b is made only if both Le and Se are present
In Le(a-b+) individual, a minute amount of Le-a antigen is still made, so no anti-Le-a antibody is produced
Even though Lewis antigen is Type 1, it can be passively adsorbed onto RBCs
Le gene expression is increased with age
Lewis type cannot be determined until 2nd birthday
Le(a-b+) individuals: as neonates, they are Le(a-b-), then Le (a+b-), then Le (a+b+), and finally Le (a-b+)
Lewis antigen decreased during pregnancy and the Le (a-b-) can transiently expressed and the patient can produce antibody which is clinically insignificant
Lewis frequency notable for: Le(a-b-) among blacks and the rarity of Le(a+b+)
BOMBAY BLOOD GROUP
Rare
Due to inherited h (an amorph) instead of H gene
Does not have H antigen– produces anti-H antibody
Can only receive donation from Bombay (H-) individuals
PARABOMBAY GROUP
In Bombay group, H produced in secretions if the Se gene is present
The H deficient secretor: para-Bombay
Still can only received blood from Bombay or para-Bombay
ABO PHENOTYPES
O blood group
No A or B genes
Only H antigen presents
Produced naturally occurring anti-A and anti-B IgM antibody
Also produces anti-A,B IgG antibody: mild ABO-related HDFN in type O mother with non-O babies
A blood group
AA or AO gene
A1 and A2 subgroups– 80% A group are A1
H antigen is more abundant in A2 vs A1 groups
Anti-A1 can be found in the serum of 5% of A2 blood group and 35% of A2B individuals- usually clinically insignificant
Differentiating A1 and A2:
Anti-A1 from B group individuals: reacted with A1.
Dolichos biflorus: has anti-A1 activity
Ulex europeaus: has anti H-activity– reacts with A2 more than A1.
B and AB blood group
B group: BB or BO
AB group: AB
ABO ANTIGENS AND ANTIBODIES
A and B antigens are made from H antigen by the enzyme products of the ABO gene.
All has H antigen:
Type 1: unbound, found in secretion
Type 2: bound to RBC surface
ABO gene– code the enzyme– the enzyme added NAG or GAL to H antigen resulting in A or B antigen
A allele produces N-acetyl galactosaminyl transferase –produce (NAG) to H– resulting in A antigen
B allele produces galactosyl transferase – produce (GAL) to H antigen– resulting in B antigen
O allele produces NO functional enzyme– produce abundant of unaltered H antigen
The relative amount of H antigen:
O»_space; A2 > B > A2B > A1 > A1B
ABO Antibodies:
Naturally occurring IgM
Detectable in infants at 3-4 months old but may not reach adult titers until 2 years old
ABO incompatibility: intravascular hemolysis, with complement activation
Major incompatibility: TRF with incompatible RBCs
Minor incompatibilities: TRF with incompatible plasma
BLOOD GROUP I
Increased post natal i antigen:High turnover RBCsBlackfan-Diamond syndromeCongenital dyserithropoetic anemia (CDA)Anti-I antibody:Anti-I abs: associated with Mycopalsma infectionAnti-i abs: associated with EBV infection
CARBOHYDRATE VS PROTEIN BLOOD GROUPS
CARBOHYDRATE
ABO, Le, I, P, M, N
Naturally occuring
IgM
React at room temp
React on IS
PROTEIN
All others including Kell, Duffy, Kidd, S
Acquired/require exposure
IgG
React at 37degC
React on AHG
ABO DISTRIBUTION
From most common to less common:
OW: 45%, B: 50%, H: 55%AW: 40%, B: 25%, H: 30%BW: 10%, B: 20%, H: 10%ABW: 5%, B: 5%, H: 3%D+W: 82%, B: 92%, H: 92%D-W: 16%, B: 8%, H: 8%
Birt-Hogg-Dube Syndrome
AD genodermatosis
Multiple fibrofolliculoma
Oncocytic neoplasm and chromophobe RCC
Lung cyst and spontaneous pneumothorax
Mutation of FLCN gene on chromosome 17, encoding protein folliculin
BROOKE SPIEGLER SYNDROME
Multiple cylindromas
Trichoepithelioma
Spiradenoma
Milia
COWDEN SYNDROME
PTEN (tumor suppressor) on chromosome 10Multiple hamartomas (mouth, GI)Thyroid follicular carcinomaBreast cancerEndometrial cancerMacrocephalyTrichilemmooooooma
MUIR TORRE SYNDROME
AD form of Lynch syndrome
Multiple sebaceous adenoma in young patient
Mutation in one of the DNA MMR MLH1, MSH2, MSH6
Associated with AKs of the skin and GI carcinomas
SWEET SYNDROME
Neutrophilic dermatosisInfections, neoplasia, pregnancy, and medications.